Find News

Filter articles

Applied Filters

Showing 1 to 10 of 1407 results

Fed Circuit invalidates Purdue oxycodone patent


The Federal Circuit has upheld a finding of the US Patent and Trademark Office, which rendered a Purdue Pharma oxycodone patent ineligible.

Hologics and Grifols agree $14m Enzo settlement


Enzo Life Sciences has entered into a settlement and licensing agreement with pharmaceutical companies Hologic and Grifols, ending a patent dispute between the parties.

Canadian generics plan could deter big pharma: report


Plans by Canada’s government to improve access to generic drugs could deter pharmaceutical companies from releasing brand medicine in the country, according to an internal government report.

SCOTUS refuses to hear tribal immunity suit


The US Supreme Court has declined to hear a closely-watched case on tribal immunity involving pharmaceutical company Allergan and the Saint Regis Mohawk Tribe, a Native American tribe.

Fresenius files IPR against Amgen


Fresenius Kabi has submitted a petition for inter partes review of US patent number 9,856,287, a patent owned by Amgen.

AG weighs in on Bayer patent case

Budapest, EU, Hungary11-04-2019

An advocate general has advised the Court of Justice of the European Union on damages in a case between Bayer and pharmaceutical companies Richter and Exeltis.

EU complains to WTO over Turkey’s pharma measures

EU, Turkey11-04-2019

The European Union has asked the World Trade Organization to initiate dispute consultations with Turkey over requirements imposed by the country on pharmaceutical products.

China, Canada and US labs collaborate over neurological disorder therapies

Canada, China, US10-04-2019

Chinese companies have entered into a research agreement with scientists in the US and Canada to develop a therapy for neurological disorders by using the natural power of the immune system.

Duane Morris hires Winston & Strawn lawyer

Taiwan, US10-04-2019

Duane Morris & Selvam has strengthened its IP practice with the addition of John Alison from Winston & Strawn.

Athena asks for rehearing on invalidated neurological disorder patent


Athena Diagnostics has asked the US Federal Circuit to revisit its decision earlier this year, which found four claims in one of its patents to be invalid.

Showing 1 to 10 of 1407 results